<DOC>
	<DOCNO>NCT02388074</DOCNO>
	<brief_summary>This single center study assess efficacy CyPath® Early Detection Lung Cancer Assay detect lung cancer cell deep lung sputum .</brief_summary>
	<brief_title>Sputum Labeling Utilizing Synthetic Meso-Tetra ( 4-Carboxyphenyl ) Porphine ( TCPP ) Detection Lung Cancer</brief_title>
	<detailed_description>Meso Tetra ( 4-Carboxyphenyl ) Porphine ( TCPP ) porphyrin label cancer cell react increased number low-density lipoprotein coat surface cancer cell porous nature cancer cell membrane , cause cell fluoresce specific wavelength light . The primary objective clinical trial determine presence absence red fluorescent [ ie , cancer ] cell ( RFCs ) deep-lung sputum sample use CyPath® Early Lung Cancer Detection Assay one cohort Participants healthy . The result trial compare two additional cohort Participants include individual high risk lung cancer individual diagnose lung cancer . Collection sputum sample high-risk individual lung cancer patient complete ( NCT00894127 ) . Participants satisfy inclusion/exclusion criterion enrol study assign healthy cohort . The sputum sample collect study site Participant 's home explanation collection procedure study staff . Samples identify identification number blind sample identity . Each subject 's sputum specimen process onto 13 microscope slide University Texas Health Science Center San Antonio ( UTHSCSA ) Laboratory . The UTHSCSA laboratory process sputum sample onto slide use ThinPrep T2000 processor use CyPath® Early Lung Cancer Detection Assay . Twelve slide sputum sample label CyPath® . One slide use preform PAP stain presence macrophage . Macrophages indication sputum sample deep within lung . A cytopathologist review slide record result specimen adequacy form . bioAffinity researcher blind Participant 's identity perform CyPath® label score slide . The study result healthy cohort use comparison result close study sputum individual high risk lung cancer individual diagnose lung cancer compare . Findings CyPath® assay use diagnosis treatment Participants .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Participants never smoke know lung disease Severe obstructive lung disease Angina minimal exertion Pregnancy Have cancer lung cancer Worked mining Industry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Lung Cancer</keyword>
	<keyword>Porphyrin</keyword>
	<keyword>Fluorescence</keyword>
	<keyword>Diagnostic</keyword>
	<keyword>Sputum Cytology</keyword>
	<keyword>Early Detection</keyword>
</DOC>